{"id":"W1886604250","doi":"10.1158/1538-7445.sabcs14-p6-12-02","title":"Abstract P6-12-02: Phase Ib dose-escalation study of an Akt inhibitor ipatasertib (Ipat) in combination with docetaxel (Doc) or paclitaxel (Pac) in patients (pts) with metastatic breast cancer (MBC)","year":2015,"lang":"en","type":"article","venue":"Cancer Research","topic":"PI3K/AKT/mTOR signaling in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":5,"is_retracted":false,"has_abstract":true,"ca_institutions":"Institute of Cancer Research","funders":"","keywords":"Medicine; Docetaxel; Metastatic breast cancer; Protein kinase B; Paclitaxel; Internal medicine; Cancer; Breast cancer; PTEN; Pharmacology; Oncology; PI3K/AKT/mTOR pathway; Chemistry; Apoptosis","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007805579,0.001472145,0.001678117,0.0006098842,0.0004770626,0.001430882,0.000944412,0.001145341,0.004598469],"category_scores_gemma":[0.0004853137,0.000733984,0.001123285,0.0006965272,0.0009085282,0.0007934005,0.0004582921,0.004426762,0.001549631],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001166777,"about_ca_system_score_gemma":0.001918448,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001452068,"about_ca_topic_score_gemma":0.003360851,"domain_scores_codex":[0.9996849,0.00008423915,0.00001764733,0.00007540017,0.00004326392,0.00009453359],"domain_scores_gemma":[0.9996462,0.00002351858,0.00005065602,0.0000354371,0.00002845811,0.0002156788],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.4721156,0.2205636,0.007359552,0.001112375,0.001272921,0.0004608324,0.0005945328,0.006291042,0.1429468,0.0006347644,0.006182685,0.1404652],"study_design_scores_gemma":[0.2844754,0.6835313,0.01187164,0.00004421664,0.0004323864,0.00044203,0.00009038355,0.001678126,0.01236673,0.000193935,0.004833248,0.00004064677],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9906057,0.0009321501,0.0004446978,0.0003069047,0.00009343422,0.003622083,0.001290239,0.0001348825,0.002569928],"genre_scores_gemma":[0.9880505,0.001068529,0.001609028,0.0005256764,0.0001016471,0.002976357,0.002054245,0.00003682587,0.003577274],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.004598469,"threshold_uncertainty_score":0.01538342,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.09496959590241856,"score_gpt":0.4208338845804653,"score_spread":0.3258642886780468,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}